Feature | June 05, 2014

Siemens Announces First U.S. Installation of Symbia Intevo xSPECT System

June 5, 2014 — Fairview Health Services, Minneapolis, recently became the first U.S. healthcare facility to install the Symbia Intevo xSPECT system from Siemens Healthcare. The first ever xSPECT system, the Symbia Intevo fully integrates single-photon emission computed tomography (SPECT) and CT during image reconstruction, combining SPECT’s high sensitivity with the high specificity of CT and completely integrating data from the two modalities to generate high resolution and, for the first time, quantitative images.

“The Symbia Intevo’s ability to truly merge SPECT and CT data provides our physicians with invaluable additional diagnostic information, helping us to differentiate cancer from other forms of disease,” said Jerry Froelich, M.D., director of nuclear medicine and molecular imaging at the University of Minnesota. “For example, with the Intevo, we are better able to identify metastatic change within an area of degenerative change, such as the spine of older patients. The supporting information of the system’s xSPECT image enables us to make these kinds of objective interpretations of disease in cases where subjective interpretations had only been possible previously.”

The Symbia Intevo xSPECT system reconstructs both the SPECT and CT portions of the image into a much higher frame of reference than previous systems. The result is precise, accurate alignment of SPECT and CT that facilitates the extraction and deep integration of medically relevant information. This ability is also the basis for differentiating tissue boundaries in bone imaging. With xSPECT Bone, physicians can potentially provide additional support for detecting – and distinguishing between – cancerous lesions and degenerative disorders. In addition, single-step reading with integrated xSPECT Bone images may reduce physician time to read and report.

xSPECT Quant delivers precise alignment of SPECT and CT, providing physicians with essential volumetric information from the CT scan. This information enables accurate and consistent quantitative assessment – a numerical indication of a tumor’s level of metabolic activity. Accurate quantitative assessment enables the physician to assess whether a patient’s course of treatment has regressed, stabilized or grown.

The statements by Siemens customers described herein are based on results that were achieved in the customer’s unique setting. Since there is no “typical” hospital and many variables exist (e.g., hospital size, case mix, level of IT adoption), there can be no guarantee that other customers will achieve the same results.

For more information: www.usa.siemens.com/healthcare

Related Content

Technology | Cardiac Imaging| May 18, 2016
May 18, 2016 — The Intersocietal Accreditation Commission (IAC) recently announced its launch of the IAC QI Self-Asse
News | Radiopharmaceuticals and Tracers| May 13, 2016
NorthStar Medical Radioisotopes LLC is enhancing its production operations at the University of Missouri Research...
GE Healthcare, general purpose digital SPECT/CT, Discovery NM/CT 670 CZT, Barnes-Jewish Hospital, first U.S. install
News | SPECT-CT| May 05, 2016
Doctors and researchers at Barnes-Jewish Hospital and Washington University in St. Louis may be able to better diagnose...
UltraSPECT, 10th anniversary, WBR technology, Wide Beam Reconstruction, FDA approval, nuclear imaging
News | Nuclear Imaging| April 21, 2016
UltraSPECT Inc. announced the 10th anniversary of the U.S. Food and Drug Administration (FDA) approval of its Wide Beam...
PET/CT scan, brain stress center, heart disease predictor, ACC.16
News | PET-CT| April 05, 2016
New research shows individuals with a greater degree of activity in the stress center of the brain also have more...
UltraSPECT, 450th U.S. installation, Firelands Regional Medical Center, nuclear medicine, radiation safety
News | Nuclear Imaging| January 27, 2016
UltraSPECT Inc. has marked the 450th U.S. installation of its low-dose image processing technology for nuclear medicine...
Siemens, Biograph Horizon PET CT, FDA clearance
Technology | PET-CT| January 21, 2016
Siemens Healthcare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Biograph...
GE Healthcare, molecular imaging, PET/CT, Discovery IQ, Discovery NM/CT 670 Pro, RSNA 2015

Discovery IQ PET/CT scanner image courtesy of GE Healthcare

News | Nuclear Imaging| November 16, 2015
GE Healthcare’s Molecular Imaging business will showcase the Discovery IQ positron emission tomography/computed...
blood clot detection, single scan, rats, radionuclides, Peter Caravan, whole body

The whole body of a rat can be imaged for blood clots with one PET scan (which is overlaid here on an MRI image) using the FBP8 probe. Arrow points to a blood clot. Image courtesy of Peter Caravan, Ph.D.

News | PET Imaging| September 23, 2015
September 23, 2015 — New research de
Overlay Init